Riskpilot← Back to searchSign inGet full accessSentrax Aktiebolag
ABActiveOrg 5561775684Ådalsvägen 3Manufacture of medical and dental instruments and supplies · NACE 3250Est. 19730 employees
Revenue 2024
SEK 0
EBITDA margin
—
-11% vs 2023
Equity ratio
84.0%
Financial strength
Net profit 2024
SEK -16K
-7% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -18K | -11% |
| Net profit | SEK -16K | -7% |
| Total assets | SEK 125K | -11% |
| Equity | SEK 105K | -13% |
| Employees | 0 | — |
Legal name
Sentrax Aktiebolag
Org number
5561775684
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
6 mars 1973
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva försäljning av dentalmaterial samt försäljning av bygginredningar och därmed förenlig verksamhet.
Address
Ådalsvägen 3
Email
aj.skartnes@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 106 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −13 | −27 | −16 | −16 | −18 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −13 | −27 | −16 | −16 | −18 |
| Net financials | −20 | −12 | −9 | −9 | 2 |
| Profit before tax | 2 | 0 | 0 | −15 | −16 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | 2 | 0 | 0 | −15 | −16 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 231 | 191 | 166 | 141 | 125 |
| Equity | 136 | 136 | 136 | 121 | 105 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 20 | 20 | 20 | 20 | 20 |
| Total debt | 20 | 20 | 20 | 20 | 20 |
EBITDA margin
-1770100.0%
This company
15.8%
Market median
-11203265% vs market
20202024
Equity ratio
84.0%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
-15.2%
This company
18.4%
Market median
-183% vs market
20202024
Net profit margin
-1603300.0%
This company
8.1%
Market median
-19793927% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sentrax Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anita Margareta Skartnes | Deputy Board Member | 0 companies |
| Jan-Peter Skartnes | Board of Directors | 0 companies |
| Jackie Jakob Skartnes | Chairman | 0 companies |